PUK14 A COST-UTILITY ANALYSIS IN A UK SETTING OF CINACALCET FOR SECONDARY HYPERPARATHYROIDISM IN END STAGE RENAL DISEASE

Autor: Mealing, SJ, Garside, R, Pitt, M, Anderson, R, D'Sousa, R, Stein, K
Zdroj: In Value in Health 2006 9(6):A388-A389
Databáze: ScienceDirect